ALB and Hepatic fibrosis: Briefly speaking, primary outcomes included clinical efficacy, indexes of hepatic fibrosis (hyaluronic acid (HA), laminin (LN), pro-collagen type III (PC-III), or collagen-IV (IV-C)), and indexes of liver function (alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB), or total bilirubin (TBil)).